USPTO serial 79300661
HELIXMITH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 2, 2021
- Examiner
- COLLOPY, DIANE PATRICIA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with HELIXMITH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for health care for treating neurological diseases, muscular diseases, ischemic diseases, renal diseases, cancer, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; Crude medicines for treating neurological diseases, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related disease; Pharmaceutical preparations extracted from crude medicine for treating neurological diseases, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; reagents for use in veterinary genetic testing; dietary supplement drinks; dietary supplements; chemical preparations for pharmaceutical purposes for treating chemical imbalances; Gene therapy preparations for treating neurological diseases, muscular diseases, ischemic diseases, renal diseases, or cancer; Drugs for medical purposes for treating neurological diseases, muscular diseases, ischemic diseases, renal diseases, cancer, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; chemical preparations for use in dna analysis for medical diagnostic purposes; Biological preparations for medical for veterinary purposes for treating neurological diseases, muscular diseases, ischemic diseases, renal diseases, or cancer; reagents for use in medical genetic testing; Pharmaceutical drugs for treating neurological diseases, muscular diseases, ischemic diseases, renal diseases, cancer, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; Medicines for human purposes for treating neurological diseases, muscular diseases, ischemic diseases, renal diseases, cancer, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; Pharmaceutical preparations for diagnosis for cancer or renal diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; Ethical medicinal preparations for the treatment of neurological diseases, muscular diseases, ischemic diseases, renal diseases, cancer, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; nutraceutical preparations for therapeutic or medical purposes; Therapeutic drugs and agents for the treatment of neurological diseases, muscular diseases, ischemic diseases, renal diseases, cancer, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; health functional food being dietetic foods mainly based on Korean herbal medicines | ACTIVE | — |
| 035 | Retail store services featuring reagents for use in veterinary genetic testing; retail store services featuring chemical preparations for pharmaceutical purposes; wholesale store services featuring gene therapy preparations; retail store services featuring gene therapy preparations; retail services by direct solicitation by sales agents in the field of gene therapy preparations; retail store services featuring chemical preparations for use in DNA analysis for medical purposes; retail store services featuring biological preparations for medical or veterinary purposes; retail store services featuring drugs for medical purposes; retail store services featuring reagents for use in medical genetic testing; retail store services featuring pharmaceutical preparations for diagnosis; retail store services featuring pharmaceutical preparations for the treatment of immune system related diseases and disorders; retail store services featuring ethical medicinal preparations; wholesale store services featuring therapeutic drugs and agents; retail store services featuring therapeutic drugs and agents | ACTIVE | — |
| 042 | Research and development of vaccines and medicines; biotechnological research; development of new products for others in the field of biotechnology; scientific research in the fields of biomedicine; Scientific research and chemical testing services in the fields of bacteriology and virology; drug discovery services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical products development; consultancy relating to pharmaceutical research and development; pharmaceutical research and development; pharmaceutical research services; research of pharmaceuticals; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of medicine, health and pharmacology; analysis of human serum for medical research; analysis of human tissues for medical research; blood analysis services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Helixmith Co., Ltd
- Other trademarks owned by Helixmith Co., Ltd
- Other trademarks owned by Helixmith Co., Ltd
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named HELIXMITH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 16, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 25, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 25, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 2, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 2, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 17, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 17, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 15, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 28, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 28, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 28, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 14, 2021 | ALIE | ASSIGNED TO LIE | — |
| Jul 14, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 13, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 13, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 13, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 17, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 27, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 27, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 24, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 23, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 21, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 1, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 28, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 24, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |